4.6 Article

Variability and effects of bronchial colonisation In patients with moderate COPD

期刊

EUROPEAN RESPIRATORY JOURNAL
卷 35, 期 2, 页码 295-302

出版社

EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/09031936.00126808

关键词

Bronchial colonisation; chronic obstructive pulmonary disease; Haemophilus influenzae; interleukin-1 beta; interieukin-12; potentially pathogenic microorganisms

资金

  1. Fondo de Investigacion Sanitaria [PI060684]
  2. Red Respira Instituto de Salud Carlos III [(ISCIII)-RTIC-03/11]
  3. Fundacio Catalana de Pbeumologia [CB06/06/1089]

向作者/读者索取更多资源

Sputum and lung function were periodically assessed in stable moderate chronic obstructive pulmonary disease (COPD) outpatients to determine relationships between bronchial colonisation and inflammation. Relationships between potentially pathogenic microorganism (PPM) typology, bronchial inflammation (neutrophilia, tumour necrosis factor-alpha, interleukin (IL)-1 beta, IL-6, IL-8, IL-10 and IL-12 and post-bronchodilator decline in forced expiratory volume in 1 s (FEV1) were analysed. PPMs periodically showing the same molecular profile using pulse field gel electrophoresis were considered long-term persistent. Bronchial colonisation was observed in 56 out of 79 follow-up examinations (70.9%) and was mainly due to Haemophilus influenzae, Pseudomonas aeruginosa and enterobacteria (n=47). These PPMs were all related to sputum neutrophilia (p <= 0.05, Chi-squared test), and H. influenzae was related to higher levels of IL-1 beta (p=0.005) and IL-12 (p=0.01), with a dose-response relationship (Spearman's correlation coefficient of 0.38 for IL-1 beta (p=0.001), and of 0.32 for IL-12 (p=0.006)). Haemophilus parainfluenzae was not associated with an identifiable inflammatory response. Long-term persistence of the same strain was observed in 12 examinations (21.4%), mainly due to P. aeruginosa or enterobacteria. A neutrophilic bronchial inflammatory response was associated with a statistically significant decline in FEV1 during follow-up (OR 2.67, 95% CI 1.07-6.62). A load-related relationship to bronchial inflammation in moderate COPD was observed for colonisation by H. influenzae, but not for colonisation by H. parainfluenzae.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Respiratory System

CT in COPD: To be or not to be

Alvar Agusti, Rosa Faner

RESPIROLOGY (2022)

Article Medicine, General & Internal

Profile of Clinical and Analytical Parameters in Bronchiectasis Patients during the COVID-19 Pandemic: A One-Year Follow-Up Pilot Study

Liyun Qin, Filipe Goncalves-Carvalho, Yingchen Xia, Jianhua Zha, Mireia Admetllo, Jose Maria Maiques, Sandra Esteban-Cuco, Xavier Duran, Alicia Marin, Esther Barreiro

Summary: The COVID-19 pandemic may have influenced the management and clinical outcomes of bronchiectasis patients over a one-year follow-up period. The study found an increase in disease severity scores and exacerbation numbers, as well as a decrease in lung function, acute phase-reactants, and immunoglobulins in bronchiectasis patients despite stable hospitalization rates.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Respiratory System

Treatable traits in the NOVELTY study

Alvar Agusti, Eleni Rapsomaniki, Richard Beasley, Rod Hughes, Hana Mullerova, Alberto Papi, Ian D. Pavord, Maarten van den Berge, Rosa Faner

Summary: This study assessed the prevalence and relationship of treatable traits (TTs) to the diagnostic label and disease severity in real-world setting for patients with asthma, COPD, or both. The results provide the largest and most granular characterization of TTs in patients with airway diseases to date.

RESPIROLOGY (2022)

Editorial Material Physiology

World COPD Day 2022: your lungs for life

Alvar Agusti, Claus F. Vogelmeier

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2022)

Article Respiratory System

Lung function in young adults born small for gestational age at term

Kilian Vellve, Alvaro Sepulveda-Martinez, Merida Rodriguez-Lopez, Francesca Crovetto, Gabriel Bernardino, Felip Burgos, Rosa Faner, Alvar Agusti, Bart Bijnens, Eduard Gratacos, Fatima Crispi, Isabel Blanco

RESPIROLOGY (2023)

Review Allergy

Treatable Traits in Airway Disease: From Theory to Practice

Alvar Agusti, Peter G. Gibson, Vanessa M. McDonald

Summary: Chronic airway diseases, such as asthma and chronic obstructive pulmonary disease, often coexist in the same patient. The treatable traits (TT) strategy, based on identifying and treating recognizable characteristics, aims to improve clinical outcomes. TTs can coexist and are not limited to specific diagnostic labels like asthma or COPD. There is solid evidence supporting the adequacy and validity of the TT strategy, and this review discusses the theoretical background and implementation in clinical practice.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Article Respiratory System

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

Alvar Agusti, Bartolome R. Celli, Gerard J. Criner, David Halpin, Antonio Anzueto, Peter Barnes, Jean Bourbeau, MeiLan K. Han, Fernando J. Martinez, Maria Montes de Oca, Kevin Mortimer, Alberto Papi, Ian Pavord, Nicolas Roche, Sundeep Salvi, Don D. Sin, Dave Singh, Robert Stockley, M. Victorina Lopez Varela, Jadwiga A. Wedzicha, Claus F. Vogelmeier

RESPIROLOGY (2023)

Article Allergy

Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

Rod Hughes, Eleni Rapsomaniki, Aruna T. Bansal, Jorgen Vestbo, David Price, Alvar Agusti, Richard Beasley, Malin Fageras, Marianna Alacqua, Alberto Papi, Hana Mullerova, Helen K. Reddel

Summary: Cluster analysis in patients with asthma and/or COPD identified distinct clusters with characteristics that differed from conventional diagnostic features. The overlap between clusters suggests that they do not reflect discrete underlying mechanisms.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Letter Critical Care Medicine

Microbiological Monitoring in Therapeutic Trials in Chronic Obstructive Pulmonary Disease

Miguel Angel Martinez-Garcia, Alvar Agusti

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Critical Care Medicine

Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease

Surya P. Bhatt, Alvar Agusti, Mona Bafadhel, Stephanie A. Christenson, Jessica Bon, Gavin C. Donaldson, Don D. Sin, Jadwiga A. Wedzicha, Fernando J. Martinez

Summary: Chronic obstructive pulmonary disease is a major health problem with acute exacerbations that have limited improvements in outcomes. It is important to identify different etioendophenotypes to develop novel therapies.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Review Cardiac & Cardiovascular Systems

Clinical characteristics of chronic obstructive pulmonary disease in never-smokers: A systematic review

Carlota Rodriguez Garcia, Alberto Ruano-Ravina, Monica Perez Rios, Lucia Martin Gisbert, Leonor Varela-Lema, Cristina Candal-Pedreira, Cristina Represas-Represas, Julia Rey-Brandariz, Luis Valdes-Cuadradoa, Alvar Agusti

Summary: Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death worldwide. While smoking is a major risk factor, COPD also occurs in individuals who have never smoked (NS). However, there is limited evidence on the risk factors, clinical characteristics, and natural history of COPD in NS. This study aimed to address this knowledge gap through a systematic review of the literature.

RESPIRATORY MEDICINE (2023)

Review Cardiac & Cardiovascular Systems

When GETomics meets aging and exercise in COPD

D. Pellegrino, S. Casas-Recasens, R. Faner, P. Palange, A. Agusti

Summary: The term GETomics refers to the concept that human health and disease are the result of dynamic gene-environment interactions occurring throughout a person's lifetime. This approach has led to a dramatic shift in our understanding of chronic obstructive pulmonary disease (COPD), as it is not solely caused by smoking and affects both genders and different age groups. By applying a GETomics approach, new perspectives on the relationship between COPD, exercise limitation, and aging can be gained.

RESPIRATORY MEDICINE (2023)

Article Respiratory System

Supranormal lung function: Prevalence, associated factors and clinical manifestations across the lifespan

Caspar Schiffers, Rosa Faner, Alina Ofenheimer, Owat Sunanta, Patricia Puchhammer, Tobias Mraz, Marie-Kathrin Breyer, Otto Chris Burghuber, Sylvia Hartl, Alvar Agusti, Robab Breyer-Kohansal

Summary: This study investigated the prevalence and characteristics of individuals with supranormal FEV1 or FVC values in different age groups. It found that approximately 3% of the general population have supranormal values, which are associated with better health markers. Factors such as female sex, higher muscle mass, less diabetes, and fewer respiratory symptoms are consistently associated with supranormal values.

RESPIROLOGY (2023)

Article Primary Health Care

Gold 2023: Highlights for primary care

Alvar Agusti, Antoni Siso-Almirall, Miguel Roman, Claus F. Vogelmeier, Sci Comm GOLD

NPJ PRIMARY CARE RESPIRATORY MEDICINE (2023)

Review Respiratory System

Advances in diagnostic tools for respiratory tract infections: from tuberculosis to COVID-19-changing paradigms?

Zoran Stojanovic, Filipe Goncalves-Carvalho, Alicia Marin, Jorge Abad Capa, Jose Dominguez, Irene Latorre, Alicia Lacoma, Cristina Prat-Aymerich

Summary: Respiratory tract infections are common reasons for seeking healthcare and pose challenges in clinical decision-making. Proper and timely diagnosis is crucial for effective management and prevention of antibiotic resistance. Diagnostic tools for respiratory tract infections include clinical features, radiology, laboratory methods, and combined algorithms. Recent advancements in diagnostic technologies, including genomics and digital transformation, have revolutionized the field and provided new opportunities for effectively dealing with epidemics and antimicrobial resistance.

ERJ OPEN RESEARCH (2022)

暂无数据